Latest Insider Transactions at Biolife Solutions Inc (BLFS)
This section provides a real-time view of insider transactions for Biolife Solutions Inc (BLFS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of BIOLIFE SOLUTIONS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of BIOLIFE SOLUTIONS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 29
2021
|
Roderick De Greef President and CEO |
SELL
Open market or private sale
|
Direct |
705
-0.68%
|
$27,495
$39.37 P/Share
|
|
Dec 29
2021
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
928
-0.36%
|
$36,192
$39.37 P/Share
|
|
Dec 29
2021
|
Karen A. Foster Chief Quality and Operations |
SELL
Open market or private sale
|
Direct |
625
-0.89%
|
$24,375
$39.37 P/Share
|
|
Dec 29
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
736
-0.36%
|
$28,704
$39.37 P/Share
|
|
Dec 22
2021
|
Troy Wichterman Chief Financial Officer |
BUY
Open market or private sale
|
Direct |
310
+1.38%
|
$11,780
$38.49 P/Share
|
|
Dec 15
2021
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
16,666
-6.02%
|
$533,312
$32.8 P/Share
|
|
Dec 15
2021
|
Michael Rice |
BUY
Exercise of conversion of derivative security
|
Direct |
16,666
+5.67%
|
$16,666
$1.78 P/Share
|
|
Dec 13
2021
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
16,666
-6.02%
|
$549,978
$33.82 P/Share
|
|
Dec 13
2021
|
Michael Rice |
BUY
Exercise of conversion of derivative security
|
Direct |
16,666
+5.67%
|
$16,666
$1.78 P/Share
|
|
Dec 09
2021
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
11,464
-4.22%
|
$401,240
$35.15 P/Share
|
|
Dec 09
2021
|
Michael Rice |
BUY
Exercise of conversion of derivative security
|
Direct |
11,464
+4.05%
|
$11,464
$1.64 P/Share
|
|
Dec 08
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
8,853
-4.11%
|
$318,708
$36.49 P/Share
|
|
Dec 08
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,853
+3.94%
|
$8,853
$1.64 P/Share
|
|
Dec 07
2021
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
11,461
-4.22%
|
$412,596
$36.52 P/Share
|
|
Dec 07
2021
|
Michael Rice |
BUY
Exercise of conversion of derivative security
|
Direct |
11,461
+4.05%
|
$11,461
$1.64 P/Share
|
|
Dec 07
2021
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
10,000
-11.41%
|
$360,000
$36.52 P/Share
|
|
Dec 07
2021
|
Todd Berard Chief Marketing Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+10.24%
|
$20,000
$2.62 P/Share
|
|
Dec 06
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,000
-4.61%
|
$340,000
$34.39 P/Share
|
|
Dec 06
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+4.41%
|
$10,000
$1.64 P/Share
|
|
Nov 30
2021
|
Troy Wichterman Chief Financial Officer |
BUY
Open market or private sale
|
Direct |
33
+0.15%
|
$1,221
$37.59 P/Share
|
|
Nov 30
2021
|
Michael Rice |
BUY
Open market or private sale
|
Direct |
957
+0.37%
|
$35,409
$37.59 P/Share
|
|
Nov 30
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Open market or private sale
|
Direct |
448
+0.22%
|
$16,576
$37.59 P/Share
|
|
Nov 30
2021
|
Karen A. Foster Chief Quality and Operations |
SELL
Open market or private sale
|
Direct |
315
-0.45%
|
$11,655
$37.59 P/Share
|
|
Nov 22
2021
|
Karen A. Foster Chief Quality and Operations |
SELL
Open market or private sale
|
Direct |
16,332
-18.75%
|
$751,272
$46.19 P/Share
|
|
Nov 22
2021
|
Karen A. Foster Chief Quality and Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
16,332
+15.79%
|
$16,332
$1.64 P/Share
|
|
Nov 18
2021
|
Roderick De Greef President and CEO |
SELL
Open market or private sale
|
Direct |
7,000
-6.34%
|
$350,000
$50.75 P/Share
|
|
Nov 17
2021
|
Roderick De Greef President and CEO |
SELL
Open market or private sale
|
Direct |
7,000
-5.97%
|
$357,000
$51.08 P/Share
|
|
Nov 17
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,000
-4.6%
|
$510,000
$51.07 P/Share
|
|
Nov 17
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+4.4%
|
$10,000
$1.64 P/Share
|
|
Nov 16
2021
|
Roderick De Greef President and CEO |
SELL
Open market or private sale
|
Direct |
7,000
-5.63%
|
$357,000
$51.39 P/Share
|
|
Nov 16
2021
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
6,160
-7.35%
|
$308,000
$50.63 P/Share
|
|
Nov 16
2021
|
Todd Berard Chief Marketing Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,160
+6.85%
|
$6,160
$1.64 P/Share
|
|
Nov 15
2021
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
6,160
-7.35%
|
$289,520
$47.96 P/Share
|
|
Nov 15
2021
|
Todd Berard Chief Marketing Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,160
+6.85%
|
$6,160
$1.64 P/Share
|
|
Nov 15
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,000
-4.6%
|
$480,000
$48.11 P/Share
|
|
Nov 15
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+4.4%
|
$10,000
$1.64 P/Share
|
|
Nov 09
2021
|
Marcus Schulz Chief Revenue Officer |
SELL
Open market or private sale
|
Direct |
1,750
-5.68%
|
$92,750
$53.0 P/Share
|
|
Nov 04
2021
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
11,461
-4.2%
|
$641,816
$56.81 P/Share
|
|
Nov 04
2021
|
Michael Rice |
BUY
Exercise of conversion of derivative security
|
Direct |
11,461
+4.03%
|
$11,461
$1.64 P/Share
|
|
Nov 02
2021
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
11,461
-4.2%
|
$618,894
$54.72 P/Share
|
|
Nov 02
2021
|
Michael Rice |
BUY
Exercise of conversion of derivative security
|
Direct |
11,461
+4.03%
|
$11,461
$1.64 P/Share
|
|
Oct 25
2021
|
Karen A. Foster Chief Quality and Operations |
SELL
Open market or private sale
|
Direct |
16,332
-18.75%
|
$718,608
$44.45 P/Share
|
|
Oct 25
2021
|
Karen A. Foster Chief Quality and Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
16,332
+15.79%
|
$16,332
$1.64 P/Share
|
|
Oct 25
2021
|
Roderick De Greef President and CEO |
SELL
Open market or private sale
|
Direct |
2,371
-1.87%
|
$104,324
$44.62 P/Share
|
|
Oct 20
2021
|
Sarah Aebersold Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
272
-1.37%
|
$11,424
$42.34 P/Share
|
|
Oct 20
2021
|
Marcus Schulz Chief Revenue Officer |
SELL
Open market or private sale
|
Direct |
399
-1.28%
|
$16,758
$42.34 P/Share
|
|
Oct 20
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,000
-4.6%
|
$410,000
$41.97 P/Share
|
|
Oct 20
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+4.4%
|
$10,000
$1.64 P/Share
|
|
Oct 18
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,000
-4.6%
|
$410,000
$41.34 P/Share
|
|
Oct 18
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+4.4%
|
$10,000
$1.64 P/Share
|